KLF4 and pneumococcal pneumonia: In the present study, we identified the transcription factor KLF4 in myeloid cells such as phagocytes as potent mediator of the early pro-inflammatory innate immune response and, therefore, as potentially interesting target for therapeutic interventions in pneumococcal pneumonia.